The temporality of economic decisions applied to clinical reasoning
DOI:
https://doi.org/10.17267/2675-021Xevidence.2024.e5435Keywords:
Clinical Decision-Making, Cost-Benefit Analysis, Economics, MedicalAbstract
INTRODUCTION: Medical thinking lacks economic thinking although temporality plays a crucial role in shared clinical decision-making. Present benefits, such as symptom relief, at times, should not be underestimated in the economic evaluation of medical interventions; and immediate effects in present benefit scenarios allow for valuable feedback, aiding in the assessment of the appropriateness of the chosen intervention. Ultimately, we underscore the need for a nuanced understanding of the interplay between time, costs, and benefits in clinical decision-making.
Downloads
References
(1) Attema AE, Brouwer WBF, Claxton K. Discounting in Economic Evaluations. Pharmacoeconomics. 2018;36(7):745–58. https://doi.org/10.1007/s40273-018-0672-z
(2) Yao Y, Zhou Y, Yang Z, Huang H, Shen H. Adjuvant Chemotherapy Following Surgical Resection Improves Survival in Patients With Early Stage Small Cell Lung Cancer. Oncol Res. 2019;27(2):203-210. https://doi.org/10.3727/096504018X15202953107093.
(3) Korenstein D, Falk R, Howell EA, Bishop T, Keyhani S. Overuse of health care services in the United States: An understudied problem. Arch Intern Med. 2012;172(2):171–8. https://doi.org/10.1001/archinternmed.2011.772
(4) Marmot M, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: An independent review. Lancet. 2012;380(9855):1778–86. http://dx.doi.org/10.1016/S0140-6736(12)61611-0
(5) Bansilal S, Farkouh ME, Hueb W, Ogdie M, Dangas G, Lansky AJ, et al. The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and angiographic profile at study entry. Am Heart J. 2012;164(4):591–9. http://dx.doi.org/10.1016/j.ahj.2012.06.012
(6) Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE. Cardiovascular Safety of Testosterone-Replacement Therapy. The New England Journal of Medicine. 2023;389(2):107–117. https://doi.org/10.1056/NEJMoa2215025
(7) Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017;112(7):988–1013. http://dx.doi.org/10.1038/ajg.2017.154
(8) Taneva B, Caparoska D. The impact of treatment with beta-blockers upon mortality in chronic heart failure patients. Open Access Maced J Med Sci. 2016;4(1):94–7. https://doi.org/10.3889/oamjms.2016.022
(9) Radziuk AL, Kieling RR, Santos K, Rotert R, Bastos F, Palmini AL. Methylphenidate improves the quality of life of children and adolescents with ADHD and difficult-to-treat epilepsies. Epilepsy Behav. 2015;46:215–20. http://dx.doi.org/10.1016/j.yebeh.2015.02.019
(10) Ghouse AA, Sanches M, Zunta-Soares G, Swann AC, Soares JC. Overdiagnosis of bipolar disorder: A critical analysis of the literature. Sci World J. 2013;2013:297087. https://doi.org/10.1155/2013/297087
Downloads
Published
Issue
Section
License
Copyright (c) 2024 João Victor Almeida dos Santos, Luís Cláudio Lemos Correia
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain copyrights, transferring to the Journal of Evidence-Based Healthcare only the right of first publication. This work is licensed under a Creative Commons Attribution 4.0 International License.
